Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Alvotech (ALVO) vs Perrigo Company plc (PRGO)

Alvotech and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $2.3B against $2.1B — 1.1× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against −4.19%. Perrigo Company plc has the higher net margin (−41.9% vs −101.1%) and the lower return on invested capital (−18.1% vs 0.00%). Across the 16 metrics below, Alvotech leads on 8 and Perrigo Company plc on 8.

Valuation

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 5.77 0.52 2.25
P/B n/m 0.85 1.90
Price to free cash flow n/m 16.85 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 9.74 1.22 2.56
Earnings yield (20.81%) (81.06%) (2.99%)
Free cash flow yield (12.51%) 5.93% 0.00%

Profitability

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Gross margin 42.71% 33.26% 53.94%
Operating margin (42.43%) (37.71%) 0.00%
Net margin (101.05%) (41.85%) 0.00%
Free cash flow margin 0.00% 2.88% 0.00%
Return on equity 0.00% (49.65%) (0.40%)
Return on assets 0.00% (19.60%) (3.32%)
Return on invested capital 0.00% (18.06%) 0.00%

Growth

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% (4.19%) 10.01%
EPS growth (last fiscal year) 111.49% (723.20%) —
Revenue growth, 5-year CAGR — 0.79% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 1.31 0.05
Current ratio 1.65 2.32 2.31
Net debt to EBITDA 9.71 (4.01) 0.85

Dividend

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Dividend yield — 3.42% 1.70%
Payout ratio 0.00 — 0.00

Size

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Market cap 2.30b 2.05b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack